Beryl Capital Management LLC 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 1:51 pm Sale | 2022-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO | Beryl Capital Management LLC | 0 0.000% | -12,303![]() (Position Closed) | Filing |
2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO | Beryl Capital Management LLC | 12,303 6.700% | 12,303![]() (New Position) | Filing |